Journal
NEUROPSYCHOPHARMACOLOGY
Volume 23, Issue 4, Pages 351-364Publisher
NATURE PUBLISHING GROUP
DOI: 10.1016/S0893-133X(00)00121-4
Keywords
schizophrenia; cigarettes; human brain; nicotine; nicotinic receptors; postmortem; receptor binding; smoking
Categories
Funding
- NIAAA NIH HHS [AA11164] Funding Source: Medline
- NIDA NIH HHS [DA09457, DA12281] Funding Source: Medline
Ask authors/readers for more resources
Previous studies have suggested that an abnormality in neuronal nicotinic acetylcholine receptor expression or function may be involved in the neuropathophysiology of schizophrenia. [H-3]-nicotine and [H-3]-epibatidine binding were compared in postmortem brain from control and schizophrenic subjects with varying smoking histories. In control subjects, increased receptor binding was seen in hippocampus, cortex, and caudate with increasing tobacco use. In contrast, schizophrenic smokers had reduced nicotinic receptor levels in these brain regions compared to control smokers. Chronic haloperidol and nicotine treatment, in the rat, was used to assess neuroleptic effects on receptor up-regulation by nicotine. A significant increase in cortical nicotinic receptors was seen in both nicotine treated as well as haloperidol and nicotine co-treated animals, suggesting that the abnormal regulation of high affinity neuronal nicotinic receptors in schizophrenics following nicotine use was not related to chronic neuroleptic treatment. (C) 2000 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available